City
Epaper

Mission Indradhanush improved child vaccination rates in India

By IANS | Updated: July 18, 2021 13:50 IST

New Delhi, July 18 An estimated 25.5 million children across India were vaccinated under India's Mission Indradhanush (MI) ...

Open in App

New Delhi, July 18 An estimated 25.5 million children across India were vaccinated under India's Mission Indradhanush (MI) child vaccination campaign during March 2015-July 2017, according to a study.

In December 2014, the Government of India launched MI, with the objective of increasing full immunisation coverage.

MI was a periodic intensification of the routine immunisation (PIRI) programme, which targeted unvaccinated and under-vaccinated children by allocating more resources to underserved areas.

The programme was implemented in 528 districts with low initial full immunisation coverage and high dropout rates in four phases during March 2015-July 2017.

Researchers at the Centre for Disease Dynamics, Economics and Policy (CDDEP) in Washington, the US, found that the full immunisation rate was 27 per cent higher among children under 2 years residing in districts that received the campaign during both phase 1 and 2 (intervention group) as compared with those residing elsewhere (control group).

The rate of receiving all vaccines at recommended ages was 8 per cent higher in the intervention group. Receiving doses of oral polio vaccine (OPV) birth dose, OPV dose 1 (OPV1), OPV2, OPV3, BCG, and hepatitis B birth dose vaccines were 9 per cent, 9 per cent, 11 per cent, 16 per cent, 5 per cent, and 19 per cent higher in the intervention group than the control group, respectively.

However, the study did not find improved vaccination rates for children who resided in a district that only received treatment in either phase 1 or 2.

"Our findings hold tremendous importance for India's Universal Immunization Programme. In the short term, MI-like programmes could substantially boost vaccine coverage and on-time delivery rates. However, their long-term sustainability and resource allocation decisions for immunisation will need to be evaluated further," said lead author Amit Summan, from the CDDEP.

Each year, 1.2 million Indian children die, accounting for a fifth of global under-5 deaths. Over 4,00,000 of these deaths are from vaccine-preventable diseases. An estimated 38 per cent of Indian children under the age of two years were not-fully-immunised in 2016.

India's shortage of a skilled health workforce affects child immunisation, stretching community-level health workers who serve as shared personnel for multiple tasks. Greater allocation of staff resources toward routine immunisation activities, including regularly updating immunisation records, should be a priority, the researchers suggested.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Centre for disease dynamicsOpvAmit summanindiaNew DelhiThe new delhi municipal councilDelhi south-westIndiUk-indiaRepublic of indiaIndia indiaNew-delhi
Open in App

Related Stories

National‘Harassing Crores for a Few’: Ex-CEC S.Y. Quraishi Criticises SIR Process at Lokmat National Conclave 2025

NationalLokmat National Conclave 2025: Manoj Jha Flags ‘Freebies Culture’, Says Elections Are No Longer Fair

HockeyIndia Clinches Bronze with 4-2 Win Over Argentina in FIH Men’s Junior Hockey World Cup (VIDEO)

CricketIndia vs South Africa 2025 Schedule: Full List of Matches, Dates, Venues and Fixtures

TechnologyOpenAI Offers ChatGPT Go Free for a Year in India; Check All the Features Users Can Now Access

Health Realted Stories

HealthGujarat's Foster Parent Scheme provides lifeline to orphaned children in Banaskantha

HealthFSSAI cracks down on ‘herbal tea’, says only Camellia sinensis qualifies

HealthPunjab CM approves cashless treatment of Rs 10 lakh to every family

HealthGST reforms, RDI scheme strengthened Indian pharma in 2025, innovation & access key for 2026

HealthSun Pharma’s Taro recalls over 17,000 units of antifungal shampoo in US: FDA